← Every company

Cogent Biosciences Inc SEC Filings

What Cogent Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

COGT overview →
Filings on file
115
since Mar 2, 2018
Warning signs
1
latest Jan 6, 2020
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 2, 2026
Material agreement
8-K
Read ↗
Aug 10, 2026
Quarterly report
10-Q
Read ↗
Aug 10, 2026
Results announced
8-K
Read ↗
Jun 11, 2026
Shareholder vote
8-K
Read ↗
May 5, 2026
Quarterly report
10-Q
Read ↗
May 5, 2026
Results announced
8-K
Read ↗
Feb 17, 2026
Annual report
10-K
Read ↗
Feb 17, 2026
Results announced
8-K
Read ↗
Nov 18, 2025
Material agreementNew debt
8-K
Read ↗
Nov 13, 2025
Material agreement
8-K
Read ↗
Nov 7, 2025
Quarterly report
10-Q
Read ↗
Nov 3, 2025
Results announced
8-K
Read ↗
Sep 11, 2025
Material agreementNew debt
8-K
Read ↗
Aug 5, 2025
Quarterly report
10-Q
Read ↗
Aug 5, 2025
Results announced
8-K
Read ↗
Jul 10, 2025
Results announcedMaterial agreement
8-K
Read ↗
Jun 11, 2025
Material agreementNew debt
8-K
Read ↗
Jun 5, 2025
Shareholder vote
8-K
Read ↗
May 6, 2025
Quarterly report
10-Q
Read ↗
May 6, 2025
Results announced
8-K
Read ↗
Feb 25, 2025
Annual report
10-K
Read ↗
Feb 25, 2025
Results announced
8-K
Read ↗
Nov 12, 2024
Quarterly report
10-Q
Read ↗
Nov 12, 2024
Results announced
8-K
Read ↗
Aug 6, 2024
Quarterly report
10-Q
Read ↗
Aug 6, 2024
Results announced
8-K
Read ↗
Jun 5, 2024
Shareholder vote
8-K
Read ↗
May 7, 2024
Quarterly report
10-Q
Read ↗
May 7, 2024
Results announced
8-K
Read ↗
Mar 22, 2024
Unregistered share sale
8-K
Read ↗
Feb 26, 2024
Annual report
10-K
Read ↗
Feb 26, 2024
Results announced
8-K
Read ↗
Feb 14, 2024
Material agreementUnregistered share sale
8-K
Read ↗
Nov 7, 2023
Quarterly report
10-Q
Read ↗
Nov 2, 2023
Results announced
8-K
Read ↗
Aug 8, 2023
Quarterly report
10-Q
Read ↗
Aug 8, 2023
Results announced
8-K
Read ↗
Jun 8, 2023
Material agreement
8-K
Read ↗
Jun 7, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 9, 2023
Quarterly report
10-Q
Read ↗
May 9, 2023
Results announced
8-K
Read ↗
Mar 14, 2023
Annual report
10-K
Read ↗
Mar 14, 2023
Results announced
8-K
Read ↗
Nov 14, 2022
Quarterly report
10-Q
Read ↗
Nov 14, 2022
Results announced
8-K
Read ↗
Aug 9, 2022
Quarterly report
10-Q
Read ↗
Aug 9, 2022
Results announced
8-K
Read ↗
Jun 16, 2022
Material agreement
8-K/A
Read ↗
Jun 15, 2022
Material agreement
8-K
Read ↗
Jun 10, 2022
Shareholder vote
8-K
Read ↗
May 10, 2022
Quarterly report
10-Q
Read ↗
May 10, 2022
Results announced
8-K
Read ↗
May 6, 2022
Material agreement
8-K
Read ↗
Mar 15, 2022
Annual report
10-K
Read ↗
Mar 15, 2022
Results announced
8-K
Read ↗
Dec 27, 2021
Executive or director change
8-K
Read ↗
Nov 10, 2021
Quarterly report
10-Q
Read ↗
Nov 10, 2021
Results announced
8-K
Read ↗
Aug 16, 2021
Quarterly report
10-Q
Read ↗
Aug 16, 2021
Results announced
8-K
Read ↗
Jul 9, 2021
Material agreement
8-K
Read ↗
Jun 17, 2021
Executive or director changeShareholder vote
8-K
Read ↗
May 12, 2021
Quarterly report
10-Q
Read ↗
May 12, 2021
Results announced
8-K
Read ↗
Mar 16, 2021
Annual report
10-K
Read ↗
Mar 16, 2021
Results announced
8-K
Read ↗
Feb 22, 2021
Executive or director change
8-K
Read ↗
Dec 2, 2020
Material agreement
8-K
Read ↗
Nov 9, 2020
Quarterly report
10-Q
Read ↗
Nov 9, 2020
Results announcedShareholder vote
8-K
Read ↗
Oct 26, 2020
Executive or director change
8-K
Read ↗
Oct 23, 2020
Executive or director change
8-K
Read ↗
Oct 9, 2020
Merger vote or registration
DEFM14A
Read ↗
Oct 6, 2020
Quarterly report
10-Q/A
Read ↗
Sep 3, 2020
Acquisition or sale completedMaterial agreement
8-K
Read ↗
Aug 11, 2020
Quarterly report
10-Q
Read ↗
Aug 11, 2020
Results announced
8-K
Read ↗
Aug 10, 2020
Material agreement
8-K
Read ↗
Jul 6, 2020
Executive or director changeAcquisition or sale completedMaterial agreementUnregistered share sale
8-K
Read ↗
Jun 10, 2020
Shareholder vote
8-K
Read ↗
May 15, 2020
Executive or director change
8-K
Read ↗
May 11, 2020
Quarterly report
10-Q
Read ↗
May 11, 2020
Results announced
8-K
Read ↗
Apr 8, 2020
Tender offer
SC TO-I
Read ↗
Mar 26, 2020
Annual report
10-K
Read ↗
Mar 26, 2020
Results announced
8-K
Read ↗
Mar 20, 2020
Material agreement
8-K
Read ↗
Mar 10, 2020
Shareholder vote
8-K
Read ↗
Mar 2, 2020
Restructuring
8-K
Read ↗
Jan 17, 2020
Material agreement
8-K
Read ↗
Jan 6, 2020
Delisting notice or listing transfer
8-K
Read ↗
Nov 12, 2019
Quarterly report
10-Q
Read ↗
Nov 12, 2019
Results announced
8-K
Read ↗
Aug 12, 2019
Quarterly report
10-Q
Read ↗
Aug 12, 2019
Results announced
8-K
Read ↗
Aug 5, 2019
Material agreement
8-K
Read ↗
Jul 29, 2019
Executive or director change
8-K
Read ↗
Jul 25, 2019
Executive or director change
8-K
Read ↗
Jun 25, 2019
Material agreement
8-K
Read ↗
Jun 18, 2019
Shareholder vote
8-K
Read ↗
Jun 14, 2019
Executive or director change
8-K
Read ↗
May 13, 2019
Quarterly report
10-Q
Read ↗
May 13, 2019
Results announced
8-K
Read ↗
Mar 28, 2019
Annual report
10-K
Read ↗
Mar 28, 2019
Results announced
8-K
Read ↗
Jan 23, 2019
Material agreement
8-K
Read ↗
Jan 3, 2019
Executive or director change
8-K
Read ↗
Nov 13, 2018
Results announced
8-K
Read ↗
Nov 13, 2018
Quarterly report
10-Q
Read ↗
Aug 13, 2018
Results announced
8-K
Read ↗
Aug 13, 2018
Quarterly report
10-Q
Read ↗
May 14, 2018
Results announced
8-K
Read ↗
May 14, 2018
Quarterly report
10-Q
Read ↗
Mar 29, 2018
Share offering
424B4
Read ↗
Mar 2, 2018
Share offering
S-1
Read ↗

Source: Cogent Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on COGT

Related datasets